Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer
In a recent study, patients with gastrointestinal cancers who had immune-related adverse events while taking checkpoint inhibitors had progression-free survival of 32... Read More
